Abstract
Several studies described association between increase of regulatory B cells (Breg) and tolerance in kidney transplanted patients. However, a lack of unique defining Breg markers limits their clinical potential. Breg induction by mesenchymal stem cells (MSC) has been proposed to induce and expand Breg in vitro for downstream applications, that will constitute an optimal in vitro system to improve characterization and applicability of Breg.
Original language | English |
---|---|
Pages | 103 |
Number of pages | 1 |
Publication status | Published - 27-Aug-2021 |
Externally published | Yes |
Event | 20th Biennial European Society for Organ Transplantation (ESOT) Congress - Milan, Italy Duration: 29-Aug-2021 → 1-Sept-2021 |
Conference
Conference | 20th Biennial European Society for Organ Transplantation (ESOT) Congress |
---|---|
Country/Territory | Italy |
City | Milan |
Period | 29/08/2021 → 01/09/2021 |